SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

STOK

Stoke Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 12h ago SEC0000315066-26-002860
Passive stake amendment
Actionable Insight • Neutral

Fidelity's increased passive stake is routine portfolio management. Monitor for any future conversion to a 13D filing, which would signal activist intent, but no such signal is present here.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$26.07
T+0 close · Nov 5, 2026 · via day close
Latest settled
+0.50%
T+5 · $26.20
Vs SPY
−2.79%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $26.07entry
  2. T+1 · 11d ago +1.80%α +1.49% · $26.54
  3. T+5 · 5d ago +0.50%α −2.79% · $26.20
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 7.5% beneficial ownership stake in Stoke Therapeutics as of September 30, 2026, up from 5% or greater in the prior filing. The increase from a passive holder is routine and does not signal activist intent.

Key Financial Metrics

Stake
7.5%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC reported beneficial ownership of 4,820,462.07 shares of Stoke Therapeutics common stock as of September 30, 2026
  • The stake represents 7.5% of shares outstanding
  • This is an amendment to a prior Schedule 13G, indicating an increase from the previously reported 5%+ stake
  • The filing is made under Rule 13d-1(b), confirming passive investment intent

Financial Impact

FMR LLC increased its stake to 7.5% of Stoke Therapeutics, up from at least 5% in the prior filing period

ownership percentage

Risk Factors

  • No material risks identified from this routine passive stake amendment

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002860
Document: 0000315066-26-002860-index-headers.html0000315066-26-002860
Document: 0000315066-26-002860-index.html0000315066-26-002860
Document: 0000315066-26-002860.txt0000315066-26-002860

Track record

18 reports on STOK

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +17.49% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $26.63 Now $26.63 −0.00% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $27.02 Now $26.63 −1.44% settles Feb 12
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $26.84 Now $26.63 −0.78% settles Feb 12
  4. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $26.12 Now $26.63 +1.95% settles Feb 12
  5. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $26.07 Now $26.63 +2.15% settles Feb 3
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $26.29 Now $26.63 +1.29% settles Jan 28
  7. Oct 21, 202626d ago 144 Bearish 6/10 Entry $25.70 Now $26.63 −3.62% settles Jan 20
  8. Sep 30, 20266w ago SC 13G Neutral 4/10 Entry $26.01 Now $26.63 +2.38% settles Dec 28
  9. Sep 25, 20267w ago 8-K Neutral 2/10 Entry $25.50 Now $26.63 +4.43% settles Dec 22
  10. Aug 18, 202612w ago Insider Cluster Neutral 3/10 Entry $33.03 to $26.20 Now $26.63 −19.38% ▼ −20.68% −19.13% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 7h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026